Abstract / Summary
Obesity is characterized by low‑grade chronic inflammation and impaired insulin sensitivity. Maresin‑1 (MaR1), a specialized pro‑resolving mediator, plays a critical role in terminating inflammation and supporting metabolic homeostasis; however, interventional data in humans remain scarce. This study examined whether fisetin supplementation augments the effects of concurrent interval resistance-aerobic training on Maresin‑1, pro‑inflammatory markers, and insulin resistance in obese men. In a 12‑week parallel‑group randomized controlled trial, 44 obese adult males (BMI > 30 kg/m²) completed one of four interventions: control-placebo (CP), fisetin (F) (200 mg/day), training-placebo (TP), or training-fisetin (TF). Training comprised eight resistance exercises at 60% 1RM with active rest followed by progressive aerobic bouts (50%-70% HRmax). Anthropometric and biochemical parameters, including plasma Maresin‑1, interleukin-6 (IL‑6), tumor necrosis factor-alpha (TNF‑α), fasting blood glucose (FBS), insulin, and HOMA‑IR, were assessed pre‑ and post‑intervention. Significant group × time interactions were observed for Maresin‑1 (p = 0.034), IL‑6 (p = 0.001), TNF‑α (p = 0.001), FBS (p = 0.001), insulin (p = 0.001), and HOMA‑IR (p = 0.001). Maresin‑1 increased in the TP (p = 0.001) and TF (p = 0.001) groups. IL‑6 decreased in T (p = 0.006), TF (p = 0.001), and F (p = 0.013) groups. TNF‑α decreased in all intervention groups (F, TP, and TF) (p = 0.002). FBS, insulin, and HOMA‑IR decreased significantly in all active arms (p = 0.003), with the greatest reductions in the TF group. Twelve weeks of concurrent interval resistance-aerobic training, especially when combined with fisetin, improved inflammatory resolution (↑Maresin‑1, ↓IL‑6, and ↓TNF‑α) and metabolic control (↓FBS, ↓insulin, and ↓HOMA‑IR) in obese men. The synergy between exercise‑induced adaptations and fisetin's anti‑inflammatory properties offers a promising non‑pharmacological strategy for mitigating obesity‑related metabolic risk.
Primary Source
Journal of the International Society of Sports Nutrition
Ask Prognia AI
Have questions about this randomised trial?
Prognia AI can search this source alongside 35M+ PubMed papers and current ESC, AHA, NICE, and ADA guidelines to give you a fully cited clinical answer.